Tip Card: Pomalyst (pomalidomide)

Pomalyst (pomalidomide) is an immunomodulatory agent, a drug that can modify, enhance, or suppress the functioning of the immune system. Pomalyst was approved by the U.S. Food and Drug Administration (FDA) in 2013 for the treatment of adult patients with relapsed and refractory myeloma. It is used in numerous combination regimens.

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.